Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemiaJunya Kuroda, T Maekawa|Cell Death and Differentiation|2007Cited by 65
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse modelHisayuki Yao, T Maekawa|Blood Cancer Journal|2011Cited by 49
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environmentMiki Takeuchi, T Maekawa|Cell Death and Differentiation|2010Cited by 38